Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

19 September 2020: Articles  USA

New-Onset Atrial Fibrillation Detected by Continuous Capnography Monitoring: A Case Report

Unusual clinical course, Challenging differential diagnosis, Unusual setting of medical care, Clinical situation which can not be reproduced for ethical reasons

Toby N. Weingarten1ACDEF*, Hiroshi Morimatsu2BCDE, Juan Fiorda-Diaz3BCDE, Sergio D. Bergese34ABCDE, Makiko Ariyoshi2BCDE, Juraj Sprung1CDE, Albert Dahan5ACDE, Frank J. Overdyk6ADE

DOI: 10.12659/AJCR.925510

Am J Case Rep 2020; 21:e925510

0 Comments

Abstract

BACKGROUND: Asymptomatic postoperative atrial fibrillation (AF) may go undetected. As part of a multicenter observational trial designed to develop a risk prediction score for respiratory depression, the respiratory patterns of patients admitted to standard wards were continuously assessed with capnography and pulse oximetry. The monitor measured end-tidal carbon dioxide, respiratory rate, heart rate (HR), and oxyhemoglobin saturation.

CASE REPORT: Two men ages 75 and 72 experienced abrupt and variable postoperative changes in HR consistent with AF with rapid ventricular response, coinciding with an abnormal breathing pattern with apneic episodes. In both cases, the changes were not detected by routine clinical monitoring.

CONCLUSIONS: Continuous capnography identified respiratory distress in 2 patients who experienced symptoms of AF. Continuous monitoring devices can help health care providers minimize the risk of morbidity and mortality for patients at risk of respiratory depression.

Keywords: Anesthesia, General, Atrial Fibrillation, Capnography, case reports, Postoperative Complications, Sleep apnea, obstructive, Monitoring, Physiologic, Oximetry, Respiratory Rate

Background

Patients with obstructive sleep apnea (OSA) experience intermittent episodes of nocturnal hypoxemia secondary to obstructive apneic events, leading to increased sympathetic activation that may contribute to the development of atrial fibrillation (AF) [1]. Surgical patients with underlying OSA have been found to be at increased risk of postoperative atrial fibrillation (POAF) following both cardiac and noncardiac surgery [2,3]. POAF complicating noncardiac surgery is associated with increased morbidity, mortality, and hospital costs [4–6].

A “failure to rescue” event leading to major morbidity or mortality is an event that could have been prevented intervening early when a patient has decompensation. In the United States, acute respiratory compromise events are common, frequently occur on standard wards, and have a mortality rate of approximately 40% [7]. Implementation of continuous monitoring of respiratory effort in patients hospitalized in these low-acuity settings has been advocated as a strategy to provide early recognition of decompensation, thus allowing timely intervention before a critical event [8].

One monitor that can be used for continuous cardiopulmonary monitoring in low-acuity settings is the Capnostream™ portable bedside monitor (Medtronic, Dublin, Ireland). The Capnostream™ comprehensively assesses patient oxygenation and ventilation by continuously measuring end-tidal carbon dioxide (etCO2) and respiratory rate (RR) using Microstream™ capnography, and heart rate (HR) and oxyhemoglobin saturation (SpO2) using Nellcor™ pulse oximetry (Figure 1) [9,10].

The PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) trial was a multicenter, prospective, observational study designed to develop a risk prediction score for respiratory depression on the ward (ClinicalTrials.gov Identifier: NCT02811302) [9,10]. Per study protocol, medical and surgical patients admitted to standard hospital wards who were receiving parenteral opioids underwent both routine clinical monitoring (intermittent vital sign spot checks) and blinded, continuous, electronic, cardiorespiratory monitoring for a maximum of 48 hours to detect episodes of opioid-induced respiratory depression (OIRD) [9,10]. Members of the PRODIGY Clinical Event Committee reviewed and adjudicated signals from the Capnostream™ portable bedside monitor that were consistent with respiratory depression. Additional medical history for the cases described was provided by the study sites. Study data analysis revealed 2 cases of etCO2 signal pattern consistent with obstructive breathing pattern. Initially, the HR was stable in both patients and abruptly changed to a highly variable, rapid rate consistent with atrial fibrillation with rapid ventricular response.

Case Reports

CASE 1:

The patient was a 75-year-old man with a body mass index (BMI) of 26.9 kg/m2 and a medical history significant for hypertension, cerebral infarction, and pulmonary artery and deep vein thromboses. His risk for OSA was determined to be high with a preoperative STOP-BANG (Snoring, Tired, Observed, Pressure, BMI, Age, Neck size large, Gender) score of 6. His pre-operative electrocardiogram showed normal sinus rhythm and he denied a history of dysrhythmias. The patient underwent abdominoperineal resection with a laparoscopic approach for colorectal cancer with general anesthesia supplemented by epidural analgesia. His immediate perioperative course was un-remarkable and the Capnostream™ portable bedside monitor was used. On the patient’s second postoperative day, multiple apneic events were detected by the monitor. During this time, the patient’s HR abruptly increased from the 80 to 90 beats per minute (bpm) range to a variable rate of 100 to 150 bpm (Figure 2A). This pattern continued for approximately 5 hours and then spontaneously resolved (Figure 2A, 2B). This episode occurred while the patient was in a postoperative ward, and was not detected by routine clinical monitoring (intermittent vital sign spot checks), and therefore, not treated. There were no consequences from the POAF episode.

CASE 2:

The patient was a 72-year-old man with a BMI of 24.0 kg/m2 and a history of hypertension. His risk for OSA was determined to be intermediate, based on a preoperative STOP-BANG score of 3. His preoperative electrocardiogram showed sinus brady-cardia and he denied a history of dysrhythmia. The patient underwent a partial hepatic resection under general anesthesia to treat a recurrence of colorectal cancer that had metastasized to the liver. His immediate postoperative course was unremarkable and he was transferred to the floor, where the Capnostream™ portable bedside monitor was used. Approximately 9.5 hours after surgery, multiple apneic events were detected by the Capnostream™ monitor (Figure 3). During this time, the patient’s HR increased from 60 to 90 bpm over a 5-minute period, and then increased to a variable rate between 120 and 180 bpm. This episode was not detected by routine clinical monitoring (intermittent vital sign spot checks), and therefore, was not treated. There were no consequences from the POAF episode.

Discussion

We described the cases of 2 men who developed a HR and rhythm consistent with POAF with rapid ventricular response in the setting of obstructive breathing patterns. In both cases, the dysrhythmia was asymptomatic and not detected by routine clinical monitoring. The HR variability consistent with AF was detected retrospectively on the capnography tracing that was made when these patients were on the hospital ward. The Capnostream™ portable bedside monitor was designed to continuously monitor for signs of respiratory depression [9,10]. The limitation of these 2 cases is that POAF was never diagnosed with electrocardiography. Because of the PRODIGY trial protocol, continuous cardiorespiratory monitoring was blinded in these cases. In a normal clinical environment, however, Capnostream™ portable bedside monitor is unblinded, which may enable prevention of complications associated with POAF, through early detection and appropriate medical intervention, including administration of oral anticoagulation medication.

Undetected postoperative OIRD can lead to respiratory arrest associated with increased morbidity and mortality, and has been reported to develop in patients soon after their vital signs have been found to be reassuring [11]. Intermittent assessment of vital signs in hospitalized patients who are receiving parenteral opioids is considered to have low-to-moderate sensitivity and specificity for detection of episodes of OIRD [12]. Therefore, patient safety advocacy groups are calling for continuous multimodal monitoring of respiratory status in hospitalized patients [11].

Our 2 cases illustrate the limitations of intermittent monitoring of vital signs for detection of other pathophysiologic abnormalities, such as POAF, which may result in hemodynamic instability, stroke, and other serious outcomes. As more centers adopt continuous monitoring for all hospitalized patients, the detection of these events will undoubtedly increase.

Conclusions

Recent scientific evidence suggests that capnography is a reliable method for identifying respiratory distress in surgical patients when compared with standard pulse oximetry [13]. In our case reports, respiratory distress was accompanied by episodes of cardiac dysrhythmia, which were otherwise undetected by standard monitoring of vital signs. Fortunately, in both patients, the events were self-limited. However, these events illustrate how use of continuous monitoring devices in low-acuity areas can alert health care providers to deteriorating cardio-pulmonary function, which could allow time for early intervention and mitigate the risk of patient morbidity and mortality.

Figures

Figure 1.. Capnostream™ portable respiratory monitors used in the PRODIGY trial. (A) Capnostream™ 20p respiratory monitor. (B) Capnostream™ 35 portable respiratory monitor. Both monitors display continuous readings for end-tidal carbon dioxide (etCO2), respiratory rate, heart rate (HR), and oxyhemoglobin saturation (SpO2). ©2020 Medtronic. All rights reserved. Used with the permission of Medtronic. Figure 2.. Postoperative abrupt change in heart rate (HR) consistent with atrial fibrillation in a 75-year-old man. The top panel shows exhaled end-tidal carbon dioxide (etCO2, represented by blue lines) measured with the Microstream™ capnography monitor. The dashed blue lines are alerts generated by apneic episodes (no breath detected for >30 s). The bottom panel shows oxyhemoglobin saturation (red line for SpO2) and HR (green line) measured with Nellcor™ pulse oximetry. In figure A, there is an abrupt change in HR from approximately 80 to 90 beats per minute (bpm) to a highly variable rate of 100 to 150 bpm. This change coincides with an apneic episode. In figure B, after 5 hours, there is another abrupt change, with the HR returning to the 80- to 90-bpm range. Also note the intermittent hypoxemic episodes that coincide with apneic episodes. EtCO2 – end-tidal carbon dioxide; RR – respiratory rate; SpO2 – oxyhemoglobin saturation; PR – pulse rate. Figure 3.. Postoperative changes in heart rate (HR) consistent with atrial fibrillation in a 72-year-old male. The top panel shows a highly abnormal breathing pattern marked by numerous apneic episodes (blue dashes). The bottom panel shows the HR (green) increase from the 60 beats per minute (bpm) range to 90 bpm for 5 minutes, and then an increase to a variable rate between 120 and 180 bpm. There are some associated changes in oxyhemoglobin saturation (red) consistent with hypoxemia secondary to apneic spells. EtCO2 – end-tidal carbon dioxide; RR – respiratory rate; SpO2 – oxyhemoglobin saturation; PR – pulse rate.

References:

1.. Oza N, Baveja S, Khayat R, Houmsse M, Obstructive sleep apnea and atrial fibrillation: Understanding the connection: Expert Rev Cardiovasc Ther, 2014; 12; 613-21

2.. Mokhlesi B, Hovda MD, Vekhter B, Sleep-disordered breathing and postoperative outcomes after elective surgery: Analysis of the nationwide inpatient sample: Chest, 2013; 144; 903-14

3.. Nagappa M, Ho G, Patra J, Postoperative outcomes in obstructive sleep apnea patients undergoing cardiac surgery: A systematic review and meta-analysis of comparative studies: Anesth Analg, 2017; 125; 2030-37

4.. Bhave PD, Goldman LE, Vittinghoff E, Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery: Am Heart J, 2012; 164; 918-24

5.. Polanczyk CA, Goldman L, Marcantonio ER, Supraventricular arrhythmia in patients having noncardiac surgery: Clinical correlates and effect on length of stay: Ann Intern Med, 1998; 129; 279-85

6.. Vaporciyan AA, Correa AM, Rice DC, Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: Analysis of 2588 patients: J Thorac Cardiovasc Surg, 2004; 127; 779-86

7.. Andersen LW, Berg KM, Chase M, Acute respiratory compromise on inpatient wards in the united states: Incidence, outcomes, and factors associated with in-hospital mortality: Resuscitation, 2016; 105; 123-29

8.. DeVita MA, Smith GB, Adam SK, “Identifying the hospitalised patient in crisis” – a consensus conference on the afferent limb of rapid response systems: Resuscitation, 2010; 81; 375-82

9.. Khanna AK, Bergese SD, Jungquist CR, Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: An international prospective, observational trial: Anesth Analg, 2020 [Online ahead of print]

10.. Khanna AK, Overdyk FJ, Greening C, Respiratory depression in low acuity hospital settings-seeking answers from the prodigy trial: J Crit Care, 2018; 47; 80-87

11.. Lee LA, Caplan RA, Stephens LS, Postoperative opioid-induced respiratory depression: A closed claims analysis: Anesthesiology, 2015; 122; 659-65

12.. Weinger MB, Lee LA, No patient shall be harmed by opioid-induced respiratory depression: Anesthesia Patient Safety Foundation, 2011; 26; 21-40

13.. Lam T, Nagappa M, Wong J, Continuous pulse oximetry and capnography monitoring for postoperative respiratory depression and adverse events: A systematic review and meta-analysis: Anesth Analg, 2017; 125; 2019-29

Figures

Figure 1.. Capnostream™ portable respiratory monitors used in the PRODIGY trial. (A) Capnostream™ 20p respiratory monitor. (B) Capnostream™ 35 portable respiratory monitor. Both monitors display continuous readings for end-tidal carbon dioxide (etCO2), respiratory rate, heart rate (HR), and oxyhemoglobin saturation (SpO2). ©2020 Medtronic. All rights reserved. Used with the permission of Medtronic.Figure 2.. Postoperative abrupt change in heart rate (HR) consistent with atrial fibrillation in a 75-year-old man. The top panel shows exhaled end-tidal carbon dioxide (etCO2, represented by blue lines) measured with the Microstream™ capnography monitor. The dashed blue lines are alerts generated by apneic episodes (no breath detected for >30 s). The bottom panel shows oxyhemoglobin saturation (red line for SpO2) and HR (green line) measured with Nellcor™ pulse oximetry. In figure A, there is an abrupt change in HR from approximately 80 to 90 beats per minute (bpm) to a highly variable rate of 100 to 150 bpm. This change coincides with an apneic episode. In figure B, after 5 hours, there is another abrupt change, with the HR returning to the 80- to 90-bpm range. Also note the intermittent hypoxemic episodes that coincide with apneic episodes. EtCO2 – end-tidal carbon dioxide; RR – respiratory rate; SpO2 – oxyhemoglobin saturation; PR – pulse rate.Figure 3.. Postoperative changes in heart rate (HR) consistent with atrial fibrillation in a 72-year-old male. The top panel shows a highly abnormal breathing pattern marked by numerous apneic episodes (blue dashes). The bottom panel shows the HR (green) increase from the 60 beats per minute (bpm) range to 90 bpm for 5 minutes, and then an increase to a variable rate between 120 and 180 bpm. There are some associated changes in oxyhemoglobin saturation (red) consistent with hypoxemia secondary to apneic spells. EtCO2 – end-tidal carbon dioxide; RR – respiratory rate; SpO2 – oxyhemoglobin saturation; PR – pulse rate.

SARS-CoV-2/COVID-19

11 August 2022 : Case report  Japan

A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936496  

09 August 2022 : Case report  Japan

A Case of Segmental Arterial Mediolysis of Multiple Visceral Arteries Following Anti-COVID-19 Vaccination: ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.937505  

29 July 2022 : Case report  Indonesia

Posterior Myocardial Infarction in a 45-Year-Old Javanese Woman with a 1-Month History of COVID-19-Related ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.937105  

08 July 2022 : Case report  Australia

Unusual Case of Painful Glossitis and Xerostomia Following Vaccination with Pfizer-BioNTech SARS-CoV-2 (BNT...

Am J Case Rep In Press; DOI: 10.12659/AJCR.937212  

In Press

12 Aug 2022 : Case report  Indonesia

A 30-Day-Old Infant with Necrotizing Fasciitis of the Perineal Region Involving the Scrotum Due to Methicil...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936915  

11 Aug 2022 : Case report  Japan

A Challenging Case of Streptococcus pneumoniae Meningitis in a 64-Year-Old Woman Who Presented with Symptom...

Am J Case Rep In Press; DOI: 10.12659/AJCR.937139  

11 Aug 2022 : Case report  Japan

A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936496  

11 Aug 2022 : Case report  Italy

A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, a...

Am J Case Rep In Press; DOI: 10.12659/AJCR.935207  

Most Viewed Current Articles

13 Jul 2022 : Case report  USA

Whistling Scrotum: An Unusual Presentation of Pneumomediastinum in the Setting of an Open Scrotal Wound

DOI :10.12659/AJCR.936441

Am J Case Rep 2022; 23:e936441

23 Feb 2022 : Case report  USA

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

06 Dec 2021 : Case report  Brazil

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

17 Feb 2022 : Case report  Oman

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...

DOI :10.12659/AJCR.934399

Am J Case Rep 2022; 23:e934399

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923